about
Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western KenyaSpatial variation of Anopheles-transmitted Wuchereria bancrofti and Plasmodium falciparum infection densities in Papua New GuineaThe role of animal models for research on severe malariaGlobal eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmesThe impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New GuineaReduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New GuineaSequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New GuineaPopulation genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life historyCorrection: Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New GuineaAntibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultsGeographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malariaDistinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections.Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populationsGlycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea.The dynamics of naturally acquired immunity to Plasmodium falciparum infectionEffect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensAcquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseTime-to-infection by Plasmodium falciparum is largely determined by random factors.Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen.Advances in Rift Valley fever research: insights for disease preventionErythrocyte polymorphisms and malaria parasite invasion in Papua New GuineaLymphatic filariasis in Papua New Guinea: interdisciplinary research on a national health problem.Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways.Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of KenyaFactors associated with severe human Rift Valley fever in Sangailu, Garissa County, KenyaAntibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon IslandsPerspectives on Haiti two years after the earthquake.Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New GuineaResearch challenges and gaps in malaria knowledge in Papua New Guinea.Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotesMathematical modelling and the control of lymphatic filariasis.Influence of maternal filariasis on childhood infection and immunity to Wuchereria bancrofti in KenyaToll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control studyWhy do we need to know more about mixed Plasmodium species infections in humans?Malaria Epidemiology and Control Within the International Centers of Excellence for Malaria Research
P50
Q24797832-0F5C7768-3650-44FE-8C99-4D07B6B4DE08Q24803224-13E7B168-97CF-4B44-B5BC-7A043B1D311CQ27348351-60EE54C8-0EEC-49E1-89D3-A6865E576705Q28473359-9405E77B-9498-4BB4-8CFA-8772D48600A7Q28474163-FEC4ADBC-795A-4C0C-87B4-3F55F8E84276Q28478979-7A9D86DF-DA9E-45B9-9464-BD73CDAEC02BQ28534282-6AAB9286-746A-4C2B-94D7-200E9BAC1578Q28534623-9123A201-2F27-4B5E-9B1F-7A739B121D0BQ28538318-132BF4A3-3539-4ECD-907C-942B1115EAC0Q33380213-CC82061E-D1E7-43B5-96F6-BF5C01FF505DQ33541742-480A7879-807F-485E-A534-A8434701E940Q33653151-5B594868-4AFE-4A8D-A76D-5C9E0AA0FE5DQ33749632-EA946948-46BB-468F-9B37-54CE70E9E608Q33788247-0E0BF764-E4A8-4239-898E-998E3B50866AQ33880608-DF945C4E-3A84-42BB-89DD-3AEEFA918FECQ34026347-AA5F1901-A0DB-4469-B1A3-57464D31FF8EQ34163026-4A8F61DB-E4CC-4985-BBC8-A1CD615C72D7Q34286264-D5CB5AB5-8B8B-471B-B451-2432EA465563Q34456035-94F90F4D-0DB5-4778-9165-F624CF4EADC1Q34778078-5F79D210-FC17-4CE3-8E3D-4BF30E37F6CEQ34955461-28F526E4-2A66-4E13-A243-78EE890967D9Q35030175-E7645D52-529D-4923-BAA3-3A1EFEE9424CQ35072346-15689853-BF49-4203-A2CD-B44E6FAF20B5Q35077969-044CA1BB-32F7-44E9-88B1-E9384599D4D2Q35150324-13C6F3FE-CE59-4BCF-BB74-5F3A144A3D25Q35150333-5A8A9800-0C4E-41C1-8783-A64F3D301F66Q35165344-9F9E7C18-4CE4-4211-B2EB-497832C126F2Q35165581-CD5F30FE-7859-41FB-A889-B0FA06147B57Q35170892-C6FC2E73-3598-44EE-AE95-D218A6C72A37Q35569042-6B828C7A-97BF-4DC2-9017-1BF126C00AA4Q35634185-14EDAF77-0ED3-4250-B281-2102032B29A6Q35636975-D2730C94-9A4E-41B4-9135-EEDF8769403EQ35637078-76D526CF-9F93-42A8-9043-C97B8B84A85EQ35649165-0DBFCD56-3AAE-4411-A61A-67E683EE581EQ35690828-F3B7933B-A06B-4FE1-A83F-11DCF5F9E992Q35721923-7CD56BC2-07CC-4E3A-BC03-39258F6D5759Q35802418-301C2934-2FF2-4743-BF9A-25BA814A5506Q35837250-EB576839-C00D-4DC4-B6C3-0AAEA8102E78Q35868718-86F34988-7F64-4BA9-B742-8BD131CD088AQ36071345-8CB57E1E-F783-4241-9CDF-1B6B0BC375E7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James W Kazura
@ast
James W Kazura
@en
James W Kazura
@es
James W Kazura
@nl
type
label
James W Kazura
@ast
James W Kazura
@en
James W Kazura
@es
James W Kazura
@nl
prefLabel
James W Kazura
@ast
James W Kazura
@en
James W Kazura
@es
James W Kazura
@nl
P106
P31
P496
0000-0002-6390-634X